The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market ...

A structured data ownership model—rooted in ICH GCP principles, supported by MHRA and FDA interpretations, and documented in validated system specifications—will enable sponsors to maintain compliance ...

It’s widely known that artificial intelligence (AI) is profoundly reshaping the healthcare industry. Hospitals have used AI in a variety of ways, from streamlining workflows to aiding in bedside ...

A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...

A data-minimizing way to research health data is Secure Multiparty Computation. On the successful implementation of the ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions data and AI as central to building a more ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Clinical data archiving, the movement of inactive patient information from a production electronic health record (EHR) to a long-term storage solution, has been happening at major hospitals and health ...

A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...